We have recently characterized the existence of a functional connection between NCX1 activity and metabolic substrates utilization, with particular reference to glutamate, in different in vitro pathological settings, such as cardiac and neuronal ischemia, PD and AD [36,40]. Here, SLC8A1 is linked to Alzheimer disease.